| Product Code: ETC9969735 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Malaria Treatment Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Malaria Treatment Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Malaria Treatment Market - Industry Life Cycle |
3.4 United States (US) Malaria Treatment Market - Porter's Five Forces |
3.5 United States (US) Malaria Treatment Market Revenues & Volume Share, By Agent, 2021 & 2031F |
3.6 United States (US) Malaria Treatment Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 United States (US) Malaria Treatment Market Revenues & Volume Share, By Treatment, 2021 & 2031F |
3.8 United States (US) Malaria Treatment Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.9 United States (US) Malaria Treatment Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.10 United States (US) Malaria Treatment Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.11 United States (US) Malaria Treatment Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 United States (US) Malaria Treatment Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of malaria cases in the US |
4.2.2 Growing awareness about the importance of early diagnosis and treatment of malaria |
4.2.3 Technological advancements in malaria treatment options |
4.3 Market Restraints |
4.3.1 Limited availability of effective antimalarial drugs in the US market |
4.3.2 High cost associated with malaria treatment and medications |
4.3.3 Potential side effects and resistance to existing malaria treatments |
5 United States (US) Malaria Treatment Market Trends |
6 United States (US) Malaria Treatment Market, By Types |
6.1 United States (US) Malaria Treatment Market, By Agent |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Malaria Treatment Market Revenues & Volume, By Agent, 2021- 2031F |
6.1.3 United States (US) Malaria Treatment Market Revenues & Volume, By Plasmodium Falciparum, 2021- 2031F |
6.1.4 United States (US) Malaria Treatment Market Revenues & Volume, By P. Vivax, 2021- 2031F |
6.1.5 United States (US) Malaria Treatment Market Revenues & Volume, By P. Ovale, 2021- 2031F |
6.1.6 United States (US) Malaria Treatment Market Revenues & Volume, By P. Malariae, 2021- 2031F |
6.1.7 United States (US) Malaria Treatment Market Revenues & Volume, By P. Knowlelsi, 2021- 2031F |
6.2 United States (US) Malaria Treatment Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Malaria Treatment Market Revenues & Volume, By Medication, 2021- 2031F |
6.2.3 United States (US) Malaria Treatment Market Revenues & Volume, By Vaccination, 2021- 2031F |
6.3 United States (US) Malaria Treatment Market, By Treatment |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Malaria Treatment Market Revenues & Volume, By Suppressive treatment, 2021- 2031F |
6.3.3 United States (US) Malaria Treatment Market Revenues & Volume, By Radical treatment, 2021- 2031F |
6.4 United States (US) Malaria Treatment Market, By Drug Type |
6.4.1 Overview and Analysis |
6.4.2 United States (US) Malaria Treatment Market Revenues & Volume, By Branded, 2021- 2031F |
6.4.3 United States (US) Malaria Treatment Market Revenues & Volume, By Generics, 2021- 2031F |
6.5 United States (US) Malaria Treatment Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 United States (US) Malaria Treatment Market Revenues & Volume, By Oral, 2021- 2031F |
6.5.3 United States (US) Malaria Treatment Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.6 United States (US) Malaria Treatment Market, By End User |
6.6.1 Overview and Analysis |
6.6.2 United States (US) Malaria Treatment Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 United States (US) Malaria Treatment Market Revenues & Volume, By Specialty clinics, 2021- 2031F |
6.6.4 United States (US) Malaria Treatment Market Revenues & Volume, By Home healthcare, 2021- 2031F |
6.7 United States (US) Malaria Treatment Market, By Distribution Channel |
6.7.1 Overview and Analysis |
6.7.2 United States (US) Malaria Treatment Market Revenues & Volume, By Direct tender, 2021- 2031F |
6.7.3 United States (US) Malaria Treatment Market Revenues & Volume, By Hospital pharmacies, 2021- 2031F |
6.7.4 United States (US) Malaria Treatment Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
6.7.5 United States (US) Malaria Treatment Market Revenues & Volume, By Online pharmacies, 2021- 2031F |
7 United States (US) Malaria Treatment Market Import-Export Trade Statistics |
7.1 United States (US) Malaria Treatment Market Export to Major Countries |
7.2 United States (US) Malaria Treatment Market Imports from Major Countries |
8 United States (US) Malaria Treatment Market Key Performance Indicators |
8.1 Percentage increase in the number of diagnosed malaria cases in the US |
8.2 Adoption rate of new and improved malaria treatment technologies |
8.3 Patient adherence to prescribed malaria treatment regimens |
8.4 Research and development investments in new antimalarial drugs |
8.5 Percentage of healthcare professionals trained in malaria diagnosis and treatment |
9 United States (US) Malaria Treatment Market - Opportunity Assessment |
9.1 United States (US) Malaria Treatment Market Opportunity Assessment, By Agent, 2021 & 2031F |
9.2 United States (US) Malaria Treatment Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 United States (US) Malaria Treatment Market Opportunity Assessment, By Treatment, 2021 & 2031F |
9.4 United States (US) Malaria Treatment Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.5 United States (US) Malaria Treatment Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.6 United States (US) Malaria Treatment Market Opportunity Assessment, By End User, 2021 & 2031F |
9.7 United States (US) Malaria Treatment Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 United States (US) Malaria Treatment Market - Competitive Landscape |
10.1 United States (US) Malaria Treatment Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Malaria Treatment Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here